About Lucerna
Lucerna is a biomedical research company focused on the development and implementation of green fluorescent protein. Its product portfolio includes antibodies, fluorophores, and sensors. The company offers a novel genetically-encodable system to fluorescently tag RNAs in cells that overcomes drawbacks of previously described RNA imaging systems. This system utilizes an RNA sequence element, termed Spinach, which is appended to an RNA of interest, and which “switches on” the fluorescence of an otherwise non-florescent dye. This dye is based on the structure of the fluorophore in GFP, making Spinach an RNA mimic of GFP. Lucerna aims to commercialize the Spinach technology by developing a line of toolkits that will enable researchers to easily image both mRNAs and noncoding RNAs in living cells and thereby providing insights into the function of these RNAs in cell biology and disease pathogenesis. Areas that are currently unclear but addressable with our technology include RNA trafficking, RNA degradation, toxic RNA aggregation, and other potential RNA regulatory mechanisms. Lucerna is based in New York, United States.
|
|
|
51-200 employees
View all Lucerna employees
|
|
Market Research
|
|
1(855) 582-3762
|
|
New York, NY
|
|
2010
|
Lucerna Alternatives
Frequently Asked Questions about Lucerna
Adeniyi Olayinka is the CEO of Lucerna.
The decision makers in Lucerna are Adeniyi Olayinka, Angelica Suarez, Angelo Modolo, etc. Click to Find Lucerna decision makers emails.
Lucerna Staff Directory
Search Lucerna Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
